Literature DB >> 14984067

Fluid management in patients with acute respiratory distress syndrome.

Andrew L Rosenberg1.   

Abstract

In a recent review of the data for fluid strategies and ARDS, fluid restriction or diuretic use was graded as "reasonably justifiable by available scientific evidence" and as "strongly supported by expert critical care opinion". Until the ARDS Network trial is published, only general guidelines regarding fluid management with or without specific vascular filling pressures from a pulmonary artery catheter can be made. Ultimately, the rationale for restricting fluid is to reduce hydrostatic pressures as much as possible. It seems most reasonable to maintain the lowest PAOP in ARDS patients that still maintains adequate circulating blood volume, mean arterial perfusion pressures, and cardiac output to provide sufficient oxygen delivery. Other clinical variables such as central venous pressure, urinary output, acid-base status, and lactate, serum urea nitrogen, and serum creatinine levels may help in judging the adequacy of a patient's intravascular volume, especially if central vascular pressure measurements are not available. Measures to reduce total body water, including flood restriction and diuretic use, seem to be of some benefit. Vasopressor use is especially important when systemic perfusion pressures are inadequate to maintain organ blood flow but should not be used to create supranormal levels of oxygen delivery.

Entities:  

Mesh:

Year:  2003        PMID: 14984067     DOI: 10.1016/s1078-5337(03)00036-4

Source DB:  PubMed          Journal:  Respir Care Clin N Am        ISSN: 1078-5337


  3 in total

Review 1.  Additive diuretic response of concurrent aminophylline and furosemide in children: a case series and a brief literature review.

Authors:  Paulo Sérgio Lucas da Silva; Vânia Euzébio de Aguiar; Marcelo Cunio Machado Fonseca
Journal:  J Anesth       Date:  2011-10-18       Impact factor: 2.078

2.  Enhanced fluid management with continuous venovenous hemofiltration in pediatric respiratory failure patients receiving extracorporeal membrane oxygenation support.

Authors:  Nancy G Hoover; Michael Heard; Christopher Reid; Scott Wagoner; Kristine Rogers; Jason Foland; Matthew L Paden; James D Fortenberry
Journal:  Intensive Care Med       Date:  2008-07-15       Impact factor: 17.440

3.  Electroporation-mediated gene delivery of Na+,K+ -ATPase, and ENaC subunits to the lung attenuates acute respiratory distress syndrome in a two-hit porcine model.

Authors:  Bryanna M Emr; Shreyas Roy; Michaela Kollisch-Singule; Louis A Gatto; Michael Barravecchia; Xin Lin; Jennifer L Young; Guirong Wang; Jiao Liu; Joshua Satalin; Kathleen Snyder; Gary F Nieman; David A Dean
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.